80 related articles for article (PubMed ID: 7635518)
1. An aberrant splicing using a 3' cryptic splice site within the CH1 exon induces truncated mu-chain production.
Komori T; Sugiyama H
Immunology; 1995 May; 85(1):166-70. PubMed ID: 7635518
[TBL] [Abstract][Full Text] [Related]
2. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells.
Hennig EE; Conney AH; Wei SJ
Cancer Res; 1995 Apr; 55(7):1550-8. PubMed ID: 7882364
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the 3' splice site of the leader-variable region intron of immunoglobulin heavy chain genes induces a direct splicing of leader to constant region, resulting in the production of truncated mu-chains.
Komori T; Sugiyama H
Eur J Immunogenet; 1995 Jun; 22(3):241-7. PubMed ID: 8547230
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of full-length and truncated Ig mu-chains in human B lymphocytes results from alternative splicing of a single primary RNA transcript.
Caldwell J; McElhone P; Brokaw J; Anker R; Pollok BA
J Immunol; 1991 Jun; 146(12):4344-51. PubMed ID: 1904080
[TBL] [Abstract][Full Text] [Related]
5. Alternate splice sites within the human VH gene coding sequences lead to truncated Ig mu-chains.
Mounir S; Guglielmi P; Preud'homme J; Nau F; Cogné M
J Immunol; 1990 Jan; 144(1):342-7. PubMed ID: 2104890
[TBL] [Abstract][Full Text] [Related]
6. A de novo G+1-->A mutation at the alpha 2(I) exon 16 splice donor site causes skipping of exon 16 in the cDNA of one allele of an OI type IV proband.
Filie JD; Orrison BM; Wang Q; Lewis MB; Marini JC
Hum Mutat; 1993; 2(5):380-8. PubMed ID: 8257992
[TBL] [Abstract][Full Text] [Related]
7. A 6-bp deletion at the splice donor site of the first intron resulted in aberrant splicing using a cryptic splice site within exon 1 in a patient with succinyl-CoA: 3-Ketoacid CoA transferase (SCOT) deficiency.
Fukao T; Sakurai S; Rolland MO; Zabot MT; Schulze A; Yamada K; Kondo N
Mol Genet Metab; 2006 Nov; 89(3):280-2. PubMed ID: 16765626
[TBL] [Abstract][Full Text] [Related]
8. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.
Lee PL; Gelbart T; West C; Halloran C; Beutler E
Blood Cells Mol Dis; 1998 Jun; 24(2):199-215. PubMed ID: 9642100
[TBL] [Abstract][Full Text] [Related]
9. Deletion of a splice donor site ablates expression of the following exon and produces an unphosphorylated RB protein unable to bind SV40 T antigen.
Shew JY; Chen PL; Bookstein R; Lee EY; Lee WH
Cell Growth Differ; 1990 Jan; 1(1):17-25. PubMed ID: 1964074
[TBL] [Abstract][Full Text] [Related]
10. Characterization of three splice variants and genomic organization of the mouse BMAL1 gene.
Yu W; Ikeda M; Abe H; Honma S; Ebisawa T; Yamauchi T; Honma K; Nomura M
Biochem Biophys Res Commun; 1999 Jul; 260(3):760-7. PubMed ID: 10403839
[TBL] [Abstract][Full Text] [Related]
11. Null allele at Bcd-1 locus in BALB/cByJ mice is due to a deletion in the short-chain acyl-CoA dehydrogenase gene and results in missplicing of mRNA.
Hinsdale ME; Kelly CL; Wood PA
Genomics; 1993 Jun; 16(3):605-11. PubMed ID: 8325633
[TBL] [Abstract][Full Text] [Related]
12. Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy.
Yagi M; Takeshima Y; Wada H; Nakamura H; Matsuo M
Hum Genet; 2003 Feb; 112(2):164-70. PubMed ID: 12522557
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 IVS16+6T-->C is a deleterious mutation that creates an aberrant transcript by activating a cryptic splice donor site.
Scholl T; Pyne MT; Russo D; Ward BE
Am J Med Genet; 1999 Jul; 85(2):113-6. PubMed ID: 10406662
[TBL] [Abstract][Full Text] [Related]
14. Normal isotype switching in B cells lacking the I mu exon splice donor site: evidence for multiple I mu-like germline transcripts.
Kuzin II; Ugine GD; Wu D; Young F; Chen J; Bottaro A
J Immunol; 2000 Feb; 164(3):1451-7. PubMed ID: 10640761
[TBL] [Abstract][Full Text] [Related]
15. Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.
Doyle GA; Rebecca Sheng X; Lin SS; Press DM; Grice DE; Buono RJ; Ferraro TN; Berrettini WH
Gene; 2007 Feb; 388(1-2):135-47. PubMed ID: 17156941
[TBL] [Abstract][Full Text] [Related]
16. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
17. Translational efficiency is up-regulated by alternative exon in murine IL-15 mRNA.
Nishimura H; Washizu J; Nakamura N; Enomoto A; Yoshikai Y
J Immunol; 1998 Jan; 160(2):936-42. PubMed ID: 9551932
[TBL] [Abstract][Full Text] [Related]
18. A novel single-base substitution (380C>T) that activates a 5-base downstream cryptic splice-acceptor site within exon 5 in almost all transcripts in the human mitochondrial acetoacetyl-CoA thiolase gene.
Nakamura K; Fukao T; Perez-Cerda C; Luque C; Song XQ; Naiki Y; Kohno Y; Ugarte M; Kondo N
Mol Genet Metab; 2001 Feb; 72(2):115-21. PubMed ID: 11161837
[TBL] [Abstract][Full Text] [Related]
19. A single base mutation in the 5' splice site of intron 7 of the lck gene is responsible for the deletion of exon 7 in lck mRNA of the JCaM1 cell line.
Rouer E; Brule F; Benarous R
Oncogene; 1999 Jul; 18(29):4262-8. PubMed ID: 10435639
[TBL] [Abstract][Full Text] [Related]
20. Diverse splicing pathways of the membrane IgHM pre-mRNA in a Chondrostean, the Siberian sturgeon.
Lundqvist M; Strömberg S; Bouchenot C; Pilström L; Boudinot P
Dev Comp Immunol; 2009 Apr; 33(4):507-15. PubMed ID: 19027787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
